Point-of-Care Diagnostics Market SIze 2024 by Key Players Analysis - Abbott Laboratories Inc., Siemens Healthcare, Nipro Diagnostics Inc., Johnson & Johnson, Abaxis Inc., Alere Inc.

The global point-of-care diagnostics market is witnessing growth, due to miniaturization of point-of-care testing devices, technological advancement of point-of-care devices, and healthcare decentralization. Based on product, the glucose monitoring kits segment is the largest contributor to the global point-of-care diagnostics market, due to increasing prevalence of lifestyle associated diseases, such as diabetes; whereas, the cardiac markers and infectious diseases segments are expected to grow at the fastest rate in the coming years.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/point-of-care-diagnostics-market/report-sample

The massive unexplored point-of-care diagnostics market in the emerging economies is creating ample opportunities for the growth of the global point-of-care diagnostics market, in the coming years. The advanced research and development activities and new product developments by the major players are supporting the demand of point-of-care devices, with better and cost effective point-of-care diagnostics, thus fuelling the growth of the global point-of-care diagnostics market.

Some of the factors driving the growth of the global point-of-care diagnostics market are increasing prevalence of infectious diseases, increasing prevalence of hospital acquired diseases, growing government support to increase adoption of point-of-care devices, increasing usage of home based point-of-care devices, growing geriatric population, and increasing government support to increase adoption of point-of-care devices. In addition, the increasing prevalence of lifestyle associated diseases, such as cardiovascular disease and diabetes, decreasing number of technicians in central laboratories, increasing private investment for new product development, and increasing awareness campaigns and conferences are fueling the growth of the global point-of-care diagnostics market. However, the lack of alignment with definitive central lab method, drawbacks of point-of-care testing over central lab method, and strict and time consuming regulatory approval are some of the factors, restraining the growth of the global point-of-care diagnostics market to some extent. Further, the reluctance towards changing the existing treatment practice and lack of reimbursement are also hindering the growth of the global point-of-care diagnostics market.

Browse full report at: https://www.psmarketresearch.com/market-analysis/point-of-care-diagnostics-market

The key players operating in the global point-of-care diagnostics market are Abbott Laboratories Inc., Siemens Healthcare, F Hoffmann La-Roche, Nipro Diagnostics Inc., Johnson & Johnson, Abaxis Inc., Alere Inc., Becton, Dickinson and Company, Beckman Coulter Inc., and Bayer Healthcare.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.